Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OKSI for Exercise-Induced Oxidative Stress
NCT03899454Phase 3Unknown
- Sponsor
- Universitas Negeri Semarang
- Start
- Jul 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of OKSI in oxidative stress, sponsored by Universitas Negeri Semarang. Primary endpoints: Malondialdehyde at 4 weeks and High-sensitivity Cardiac-Troponin I at 4 weeks. Status: unknown.
02
Drugs
OKSI
03
Conditions
oxidative stress
Beyond the preview
Go deeper on NCT03899454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03899454.